Small Animal Clinical Pharmacology and Therapeutics
A special issue of Animals (ISSN 2076-2615). This special issue belongs to the section "Veterinary Clinical Studies".
Deadline for manuscript submissions: closed (20 April 2024) | Viewed by 2548
Special Issue Editors
Interests: pharmacology; pharmacodynamics; pets; new companion animals; cell culture; nsaids; antibiotics; antimicrobial resistance; pharmacovigilance; pharmacosurveillance
Special Issues, Collections and Topics in MDPI journals
Interests: pharmacology; pharmacodynamics; food producing animals; cell culture; nsaids; antibiotics; antimicrobial resistance
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Companion animals are increasingly considered as family members. The level of care and cure must be adequate for such a degree of importance. Several improvements have been recorded in the clinical practice of companion animals in recent decades both in clinical and surgery fields, and pharmacology remains a milestone of both. On the one hand, pharmacology is a science mainly related to the alteration of physiological processes; on the other hand, it is strictly related to pathological conditions and is one of the few tools that can be used to treat and cure patients. These factors are well-known by all veterinarians, and they are continuously increasing. In order to collect extensive information about the current use of veterinary medicines in pets, we invite all colleagues to submit a manuscript about their experiences, from a clinical or research point of view, within veterinary pharmacology and therapeutics.
Dr. Cristina Vercelli
Prof. Dr. Giovanni Re
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Animals is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- small animal clinics
- pharmacology
- therapeutics
- new applications
- revision of previous protocols
- pharmacovigilance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.